| Small molecules capable of modulating excessive immune cell activation form the basis of Jenken's technology platform. Our compounds have exhibited good activity in reducing cell death and damages associated with exacerbated inflammatory responses and demonstrate potential as organ protectants in treating liver injuries regardless of the underlying cause of the damage. |
Overview Disease Programs Products |